What is Janux Therapeutics's debt-to-assets?

Janux Therapeutics (JANX) reported debt-to-assets of 0× in Q1 2026.

How has Janux Therapeutics's debt-to-assets changed year-over-year?

Janux Therapeutics's debt-to-assets decreased by 2.3% year-over-year, from 0× to 0×.

What is the long-term trend for Janux Therapeutics's debt-to-assets?

Over 4 years (2021 to 2025), Janux Therapeutics's debt-to-assets has grown at a 157.8% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Janux Therapeutics JANX Debt-to-assets

Debt-to-assets at other companies

Johnson & JohnsonJNJ

0.3×0.0×

AmgenAMGN

0.6×0.0×

Regeneron PharmaceuticalsREGN

0.1×0.0×

XencorXNCR

0.2×0.0×

AbbVieABBV

0.5×0.0×

Vor BiopharmaVOR

0×-0.3×

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.3%

Enterprise value$862.55M-36.2%

P/S65×-85.2×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Calculated from Janux Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's debt-to-assets?: Janux Therapeutics (JANX) reported debt-to-assets of 0× in Q1 2026.
How has Janux Therapeutics's debt-to-assets changed year-over-year?: Janux Therapeutics's debt-to-assets decreased by 2.3% year-over-year, from 0× to 0×.
What is the long-term trend for Janux Therapeutics's debt-to-assets?: Over 4 years (2021 to 2025), Janux Therapeutics's debt-to-assets has grown at a 157.8% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.